Results of Operations

for the First Quarter of the Fiscal Year Ending March 2022 (1Q FY3/22)

Welbe, Inc.

Securities Code: 6556

Revision of new business and earnings forecast

©2021 Welbe, Inc.

1

Entering the "Healthcare business"①

On July 19, 2021

Concluded a domestic exclusive agency contract for 5-ALA ingredient *

* Excludes pharmaceuticals.

manufacture

ingredient

sale

Product sales

Health food

company

(Product example:

Supplement)

Neopharma Japan Co., Ltd. operates the Fukuroi Factory, which is the only facility in the world capable of mass production of 5-ALA.

Welbe Link Inc. will become a consolidated subsidiary and change its name to "Welbe Healthcare Inc." on August 13, as the healthcare business centered on the sale of 5- ALA ingredient will expand.

food company

Pharmaceutical

(Product examples: alcoholic

company

beverages, confectionery,

(Product example: Energy

Fermented food)

drink)

©2021 Welbe, Inc.

2

Entering the "Healthcare business"②

Healthcare business

+ Disability welfare business

Short term

Medium-

to long-

term

Sales of ingredients to supplement companies, food companies, Pharmaceutical companies, etc.

Planning of original products containing 5-ALA based on research results

Promote research and development on mental disorders and developmental disorders using 5-ALA

Research Advisor

Professor Emeritus, The University of Tokyo.

Naohide Yamashita

Former hospital director of The University of

Tokyo,The Institute of Medical Science.

Aiming to create new demand in the mental health market

©2021 Welbe, Inc.

3

Revision of earnings forecast

・Revision due to the start of consolidation of Welbe Healthcare Inc.

・There is no change from the previously announced figures for existing disability welfare business ・Multiple deals in progress

Net sales

Operating profit

+407 +212

9,144 ➮ 9,551

2,446 ➮ 2,658

+4%

+8%

Ordinary profit +212（2,446 ➮ 2,659, +8%）,

Profit +137（1,772 ➮ 1,910, +7%）

©2021 Welbe, Inc.

(Before ⇨ After millions of yen ) 4

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Welbe Inc. published this content on 08 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 September 2021 08:31:08 UTC.